Diabetes poses one of today’s biggest global health challenges, affecting the lives of 415 million people worldwide.  In nearly every country, the number of people with diabetes is increasing, and by 2040, it could rise to 642 million. Diabetes has also become a growing economic burden with healthcare systems struggling to match resources with increasing needs.

Biorep’s origins can be traced back to when the company was founded in 1994.  Since then our company has developed in a way that our founders couldn’t have imagined.  We are leaders in our field, we have shipped our products globally, and hundreds of researchers rely on our products to support their diabetes cure-focused research.  And all along we stayed true to the values that have helped bring us this far.

The Biorep Mission

Biorep enables advancements in medical technologies by offering the single source solution for healthcare professionals and researchers worldwide through a collaborative commitment to the design, development, and manufacturing of innovative biomedical products to improve the quality of life for patients.


Biorep Values

Our values define who we are, what we do and how we do it. They influence the way we work with each other –and the way we serve our clients.


Biorep Technologies values originality and promotes innovative and strategic thinking to solve current medical challenges. We apply our ingenuity across all aspects of our business and in the products, services, and processes we deliver to our clients.


We understand that respect is the fundamental value for successful team work. At Biorep, we believe that honesty and reliability are essential for our progress.


We set high standards and we constantly adapt and improve our products based on feedback from the medical community. Biorep prides itself on providing innovative products of the best quality. 


We are passionate about what we do and are committed to delivering the best solutions to our clients.


We learn from each other and share our skills to enrich the creative process and to provide interdepartmental support. Biorep is committed to collaborating with professionals in the medical field and to delivering excellent service to our clients.

Our History

Thirty seven years ago, Ramon Poo knew almost nothing about diabetes. It didn’t run in his family; it wasn’t on his mind. Then his 4-year-old daughter, Cristina, was diagnosed with juvenile diabetes. That was the original driving force behind Biorep – develop the technology to help researchers find the biological cure for Type I diabetes. “We said this is something we have to do. We all have the dream of finding the cure” – Ramon E. Poo, 2002

Through a close relationship with the Diabetes Research Institute and Dr. Camillo Ricordi, we developed the equipment and method used worldwide for islet isolation research.

Throughout the development of diabetes research equipment, we learned the intricacies of medical device development and ventured into surgical instrument design and manufacturing in collaboration with renowned cardiac surgeon Dr. Joseph Lamelas. Along the way, Biorep became ISO 13485 certified, FDA registered, and built a state-of-the-art class 10,000 cleanroom.

With over ten different FDA compliant medical devices under our belt, we expanded our service offering towards other medical disciplines and are looking to establish ourselves as the leading medical device product development firm in South Florida.

Our Customers

Biorep Technologies recognizes the advances in medicine that have resulted from the research conducted by our customers in the United States and around the world. Currently, we are serving numerous research centers across the United States and 26 different countries.

History Timeline

A close family member is diagnosed with diabetes and her family is referred to the University of Miami Diabetes Research Institute.

Read more

A relationship is born with the doctors at the University of Miami Diabetes Research Institute.

Islet isolation equipment is manufactured and donated to the DRI and other leading research facilities in order to advance diabetes research.

Read more

Islet isolation and transplantation research gains support from the scientific community

Read more

Biorep is founded Islet isolation and transplantation research gains support from the scientific community.

Biorep starts distributing equipment worldwide.

Read more

Patent No. 6,833,270 is granted for an “Apparatus and Method for Isolating Cells from Organs”

Read more

Patent No. 7,188,994 is granted for the “Orbital Shaker for Cell Extraction”

Patent No. 7,186,549 is granted for the “Container for Shipping Items in an Aircraft”

Read more

Ramon E. Poo is recognized as one of the 100 most notable people in the medical device industry by MD&DI

Read more

Biorep exhibits in the IPITA-IXA Conference

Biorep Automa1c Islet Counter & Perifusion System are released

Read more

ISO 13485:2003 certification

Patent Nos
Read more

Biorep becomes registered with the FDA

Read more

Biorep creates joint-venture with Medtronic & Miami Instruments

Patent No. 8,263,389 is granted

Biorep and the DRI are awarded a Phase II grant from the NIH.

Read more

Patent No. 8,348,128 is granted for the “Anastomosis System and Method”

Read more

Patent No. 8,865,427 & 8,785,178 are granted for the “Perfusion Device”

Patent No. 8,777,084 is granted for the “Anastomosis System and Metod”

Read more

Patent application for islet cell concentrator gets allowed.

Patent No. 9,108,204 is granted

Read more

Biorep relocates to brand new facility in Miami Lakes, FL with over 6,000 ft2

Biorep builds a state-of-the-art ISO 7, Class 10,000 cleanroom

Read more

Biorep creates joint venture with Dalent Medical, LLC

Biorep launches Islet Counter v4

Read more

Biorep splits into two separate business units – Biorep Technologies and Biorep Diabetes

Biorep exhibits at HIRN in Washington D.C.

Biorep introduces Perifusion System v5

Read more

Start typing and press Enter to search